Abbott Laboratories (ABT) Retained Earnings (2009 - 2026)
Abbott Laboratories (ABT) posted Retained Earnings of $49.8 billion for Q2 2026, little changed sequentially from $50.0 billion in Q1 2026, and up 2.74% YoY from $48.5 billion in Q2 2025.
Abbott Laboratories (ABT) Retained Earnings (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Retained Earnings for 18 years, with the latest figure at $49.8 billion in Q2 2026.
- Quarterly Retained Earnings rose 2.74% year-over-year to $49.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $49.8 billion (up 2.74% YoY) and the FY2025 annual result came in at $49.8 billion, up 5.33% from the prior year.
- Retained Earnings was little changed at $49.8 billion in Q2 2026 per ABT's latest filing, from $50.0 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $50.0 billion in Q1 2026 and troughed at -$8.1 billion in Q4 2022.
- A 5-year average of $36.3 billion and a median of $38.2 billion in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings increased 2.63% in 2023, then jumped 702.9% in 2024.
- Over 5 years, Retained Earnings stood at -$8.1 billion in 2022, then climbed by 2.63% to -$7.8 billion in 2023, then jumped by 702.9% to $47.3 billion in 2024, then rose by 5.33% to $49.8 billion in 2025, then rose by 0.03% to $49.8 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $49.8 billion, $50.0 billion, and $49.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | - |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 11.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.79 Bn |
| Mar 31, 2026 | 49.96 Bn |
| Dec 31, 2025 | 49.78 Bn |
| Sep 30, 2025 | 49.10 Bn |
| Jun 30, 2025 | 48.47 Bn |
| Mar 31, 2025 | 47.72 Bn |
| Dec 31, 2024 | 47.26 Bn |
| Sep 30, 2024 | 39.06 Bn |
| Jun 30, 2024 | 38.35 Bn |
| Mar 31, 2024 | 38.01 Bn |
| Dec 31, 2023 | -7.84 Bn |
| Sep 30, 2023 | 36.92 Bn |
| Jun 30, 2023 | 36.36 Bn |
| Mar 31, 2023 | 35.87 Bn |
| Dec 31, 2022 | -8.05 Bn |
| Sep 30, 2022 | 35.12 Bn |
| Jun 30, 2022 | 34.49 Bn |
| Mar 31, 2022 | 33.30 Bn |
| Dec 31, 2021 | -8.37 Bn |
| Sep 30, 2021 | 30.38 Bn |